Publication Name	World Journal of Clinical Cases
Manuscript ID	69640
Country	China

Received	2021-07-28 10:12
Peer-Review Started	2021-07-28 10:13
To Make the First Decision
Return for Revision	2021-08-19 05:58
Revised	2021-08-24 13:39
Second Decision	2021-10-12 08:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-10-14 02:30
Articles in Press	2021-10-14 02:30
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-10-08 22:35
Typeset the Manuscript	2021-11-24 01:30
Publish the Manuscript Online	2021-11-30 09:35

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Respiratory System
Manuscript Type	Retrospective Study
Article Title	Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
Manuscript Source	Unsolicited Manuscript
All Author List	Wei Wu, Min Liu, Jiajing Geng and Mei Wang
ORCID	Author(s) ORCID Number Wei Wu http://orcid.org/0000-0002-9277-9124 Min Liu http://orcid.org/0000-0002-3574-8487 Jiajing Geng http://orcid.org/0000-0002-1082-5159 Mei Wang http://orcid.org/0000-0003-4082-3506
Funding Agency and Grant Number
Corresponding Author	Mei Wang, MHSc, Attending Doctor, Laboratory Medicine, Bejing Tongren Hosptial, Capital Medical University, No. 2 West Ring South Road, Beijing 100176, China. wmeimeiw@163.com
Key Words	Vancomycin; Teicoplanin; Methicillin-resistant Staphylococcus aureus; Methicillin-resistant Staphylococcus epidermidis; Lung infection
Core Tip	Vancomycin and teicoplanin are both essential drugs in the clinical treatment of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis lung infections and have significant antimicrobial effects on Gram-positive cocci. Here, we discuss the efficacy and safety of these two key antibiotics.
Publish Date	2021-11-30 09:35
Citation	Wu W, Liu M, Geng JJ, Wang M. Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections. World J Clin Cases 2021; 9(34): 10549-10556
URL	https://www.wjgnet.com/2307-8960/full/v9/i34/10549.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i34.10549

Full Article (PDF)	WJCC-9-10549.pdf
Full Article (Word)	WJCC-9-10549.docx
Manuscript File	69640_Auto_Edited-JLW-Filipodia.docx
Answering Reviewers	69640-Answering reviewers.pdf
Audio Core Tip	69640-Audio core tip.m4a
Biostatistics Review Certificate	69640-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	69640-Conflict-of-interest statement.pdf
Copyright License Agreement	69640-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	69640-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	69640-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	69640-Language certificate.pdf
Peer-review Report	69640-Peer-review(s).pdf
Scientific Editor Work List	69640-Scientific editor work list.pdf